NASDAQ:CDIO Cardio Diagnostics (CDIO) Stock Price, News & Analysis $1.97 +0.08 (+4.23%) As of 10:36 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Cardio Diagnostics Stock (NASDAQ:CDIO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cardio Diagnostics alerts:Sign Up Key Stats Today's Range$1.90▼$1.9650-Day Range$1.60▼$2.0752-Week Range$0.97▼$7.91Volume619 shsAverage Volume1.17 million shsMarket Capitalization$5.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Cardio Diagnostics Holdings, Inc. develops blood-based tests and technology for cardiovascular disease assessment. Its platform combines genetic and epigenetic information with artificial intelligence to support more personalized evaluation of heart disease. The company’s offerings include Epi+Gen CHD, designed to assess a person’s risk of coronary heart disease, and PrecisionCHD, a test intended to help identify coronary heart disease in people being evaluated for the condition. The tests are designed to complement clinical assessment and are not a substitute for care from a health professional. Founded in 2017 and based in Chicago, Illinois, Cardio Diagnostics was co-founded by Meesha Dogan, who serves as its chief executive officer. The company focuses primarily on making its testing services available in the United States.AI Generated. May Contain Errors. Read More Cardio Diagnostics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreCDIO MarketRank™: 0.317892221925 of 5 starsCardio Diagnostics scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingCardio Diagnostics has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCardio Diagnostics has only been the subject of 1 research reports in the past 90 days.Read more about Cardio Diagnostics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardio Diagnostics is -0.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardio Diagnostics is -0.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardio Diagnostics has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.18% of the float of Cardio Diagnostics has been sold short.Short Interest Ratio / Days to CoverCardio Diagnostics has a short interest ratio ("days to cover") of 0.27, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardio Diagnostics has recently increased by 62.77%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCardio Diagnostics does not currently pay a dividend.Dividend GrowthCardio Diagnostics does not have a long track record of dividend growth. News and Social Media1.2 / 5News Sentiment-0.01 News SentimentCardio Diagnostics has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cardio Diagnostics this week, compared to 2 articles on an average week. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cardio Diagnostics insiders have not sold or bought any company stock.Percentage Held by Insiders8.99% of the stock of Cardio Diagnostics is held by insiders.Percentage Held by Institutions8.06% of the stock of Cardio Diagnostics is held by institutions.Read more about Cardio Diagnostics' insider trading history. Receive CDIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDIO Stock News HeadlinesCardio Diagnostics’ Whitepaper Examines Clinical Blind Spot in Coronary Heart Disease Detection and CareNovember 12, 2026 | finance.yahoo.comCardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks TranscriptSeptember 18, 2026 | seekingalpha.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 16 at 1:00 AM | Weiss Ratings (Ad)Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access ChallengesAugust 26, 2026 | businesswire.comCardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks TranscriptAugust 20, 2026 | seekingalpha.comCardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026August 5, 2026 | businesswire.comCardio Diagnostics Hldgs Insider Trading Activity | NASDAQ:CDIO | BenzingaJuly 7, 2026 | benzinga.comCardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health PlansJuly 1, 2026 | finance.yahoo.comSee More Headlines CDIO Stock Analysis - Frequently Asked Questions How have CDIO shares performed this year? Cardio Diagnostics' stock was trading at $2.71 at the start of the year. Since then, CDIO shares have decreased by 30.3% and is now trading at $1.89. How were Cardio Diagnostics' earnings last quarter? Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) released its quarterly earnings data on Friday, November, 6th. The company reported ($0.59) earnings per share for the quarter. Cardio Diagnostics had a negative net margin of 40,543.75% and a negative trailing twelve-month return on equity of 89.41%. When did Cardio Diagnostics' stock split? Cardio Diagnostics's stock reverse split on Tuesday, May 13th 2025.The 1-30 reverse split was announced on Thursday, May 8th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Cardio Diagnostics? Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cardio Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardio Diagnostics investors own include Riot Platforms (RIOT), Super Micro Computer (SMCI), Tesla (TSLA), SoundHound AI (SOUN), Oracle (ORCL), Archer Aviation (ACHR) and Advanced Micro Devices (AMD). Company Calendar Last Earnings11/06/2026Today11/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (8m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CDIO's financial health is in the Yellow zone, according to TradeSmith. CDIO has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:CDIO CIK1870144 Webwww.cdio.ai Phone(855) 226-9991FaxN/AEmployees17Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.50 million Net Margins-40,543.75% Pretax Margin-40,537.50% Return on Equity-89.41% Return on Assets-82.81% Debt Debt-to-Equity RatioN/A Current Ratio17.42 Quick Ratio17.42 Sales & Book Value Annual Sales$15.19 thousand Price / Sales384.01 Cash FlowN/A Price / Cash FlowN/A Book Value$3.82 per share Price / Book0.52Miscellaneous Outstanding Shares2,960,000Free Float2,694,000Market Cap$5.83 million OptionableNot Optionable Beta2.32 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:CDIO) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsThe U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trad...Patriot Gold Group | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.